Genesis HealthCare welcomes Gerry Adest to its Board of Directors

– USA, PA –  Genesis Healthcare, Inc. (OTC: GENN), a national post-acute care provider, today announced the appointment of Gerry Adest to its Board of Directors, effective January 10, 2022.

“We are also excited to welcome Gerry to our Board. Gerry is a well-known leader in the post-acute industry and his experience and insights will be valuable as we lead Genesis into the future.” said Executive Chairman, David Harrington.

The company also announced that Bob Fish left the Board effective January 1st, 2022.

About Gerry Adest

Gerry Adest is a practicing CPA and industry consultant with over 25 years of experience with skilled nursing facilities and other areas of the long-term care spectrum. Mr. Adest has been a partner at Martin Friedman & Co. since 2018 and was a partner at Loeb & Troper LLP from 2010 to 2017. Mr. Adest graduated Cum Laude from Brooklyn College and is a member of the AICPA.

About Genesis HealthCare

Genesis Healthcare, Inc. is a holding company with subsidiaries that, on a combined basis, offer services to more than 250 skilled nursing facilities and assisted/senior living communities in 22 states nationwide. Genesis affiliates provide high-quality post-acute care, long-term care, and assisted/senior living services in the local markets in which they serve. All facilities follow a universal staff COVID-19 vaccine requirement to protect patients, residents, families, and colleagues. Genesis subsidiaries also supply rehabilitation therapy to approximately 1,100 healthcare providers in 43 states and the District of Columbia.

For more information: https://www.genesishcc.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

Talent4Boards Team